The Nurr1 7048 G 7049 intronic insertion is not associated with Parkinson's disease

被引：0
|
作者：
Healy, DG
Sleiman, P
Sweeney, MG
Khan, N
Eunson, LH
Wood, NW
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P78
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [41] Potential of Nurr1 interactions to disclose new Parkinson's therapeutics
    Federoff, Howard J.
    Brown, Milton
    Dakshanamurthy, Sivanesan
    Maguire-Zeiss, Kathleen
    FUTURE NEUROLOGY, 2009, 4 (02) : 161 - 165
  • [42] Nurr1 repression mediates cardinal features of Parkinson's disease in α-synuclein transgenic mice
    Argyrofthalmidou, Maria
    Spathis, Athanasios D.
    Maniati, Matina
    Poula, Amalia
    Katsianou, Maira A.
    Sotiriou, Evangelos
    Manousaki, Maria
    Perier, Celine
    Papapanagiotou, Ioanna
    Papadopoulou-Daifoti, Zeta
    Pitychoutis, Pothitos M.
    Alexakos, Pavlos
    Vila, Miquel
    Stefanis, Leonidas
    Vassilatis, Demetrios K.
    HUMAN MOLECULAR GENETICS, 2021, 30 (16) : 1469 - 1483
  • [43] Neuroprotective Nurr1 Agonist Therapy in Parkinson's Disease: Potential Off-Target Implications
    Steece-Collier, K.
    Collier, T. J.
    Stancati, J. A.
    Kemp, C. J.
    Daley, B. F.
    Sortwell, C. E.
    CELL TRANSPLANTATION, 2017, 26 : 726 - 726
  • [44] Decreased NURR1 and PITX3 gene expression in Chinese patients with Parkinson's disease
    Liu, H.
    Wei, L.
    Tao, Q.
    Deng, H.
    Ming, M.
    Xu, P.
    Le, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (06) : 870 - 875
  • [45] SUPPRESSION OF NURR1 EXPRESSION BY SYNUCLEIN UNDERLIES THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS IN PARKINSON'S DISEASE
    Parisiadou, L.
    Lin, X.
    Yu, J.
    Liu, G. X.
    Sun, L.
    Xie, C.
    Cai, H.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 52 - 52
  • [46] Neuroprotective Nurr1 Agonist Therapy in Parkinson's Disease: Potential Off-Target Implications
    Steece-Collier, K.
    Collier, T. J.
    Stancati, J. A.
    Kemp, C. J.
    Daley, B. F.
    Sortwell, C. E.
    CELL TRANSPLANTATION, 2017, 26 (04) : 726 - 726
  • [47] NURR1 DEFICIENCY-MEDIATED INFLAMMATORY INJURY TO NIGRAL DOPAMINE NEURONS IN PARKINSON'S DISEASE
    Dong, J.
    Wang, Y.
    Liu, X. Y.
    Le, W. D.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E66 - E66
  • [48] Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson's Disease
    Li, Tianbai
    Yang, Zhaofei
    Li, Song
    Cheng, Cheng
    Shen, Bairong
    Le, Weidong
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [49] Want of Wnt in Parkinson's disease: Could sFRP disrupt interplay between Nurr1 and Wnt signaling?
    Gamit, Naisarg
    Dharmarajan, Arun
    Sethi, Gautam
    Warrier, Sudha
    BIOCHEMICAL PHARMACOLOGY, 2023, 212
  • [50] Prostaglandin A2 Interacts with Nurr1 and Ameliorates Behavioral Deficits in Parkinson’s Disease Fly Model
    Sreekanth Rajan
    Hui Ting Toh
    Hong Ye
    Ziyin Wang
    Adeline Henry Basil
    Tanvi Parnaik
    Jun Yeob Yoo
    Kah-Leong Lim
    Ho Sup Yoon
    NeuroMolecular Medicine, 2022, 24 : 469 - 478
12345